Cannabis Strategic Ventures (Cannabis Strategic Ventures) Debt-to-Equity : -3.27 (As of Jun. 2020)

View and export this data going back to 2005. Start your Free Trial

What is Cannabis Strategic Ventures Debt-to-Equity?

Cannabis Strategic Ventures's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2020 was $15.09 Mil. Cannabis Strategic Ventures's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2020 was $7.11 Mil. Cannabis Strategic Ventures's Total Stockholders Equity for the quarter that ended in Jun. 2020 was $-6.78 Mil. Cannabis Strategic Ventures's debt to equity for the quarter that ended in Jun. 2020 was -3.27.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Cannabis Strategic Ventures's Debt-to-Equity or its related term are showing as below:

NUGS's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

Cannabis Strategic Ventures Debt-to-Equity Historical Data

The historical data trend for Cannabis Strategic Ventures's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Strategic Ventures Debt-to-Equity Chart

Cannabis Strategic Ventures Annual Data

Trend

Dec13

Dec14

Mar16

Mar17

Mar18

Mar19

Mar20

Debt-to-Equity

Get a 7-Day Free Trial

1.48

-3.73

Cannabis Strategic Ventures Quarterly Data
	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20
Debt-to-Equity	Get a 7-Day Free Trial															50.82	-11.30	-7.49	-3.73	-3.27

Competitive Comparison of Cannabis Strategic Ventures's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Strategic Ventures's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Strategic Ventures's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Strategic Ventures's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Cannabis Strategic Ventures's Debt-to-Equity falls into.

Cannabis Strategic Ventures Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Cannabis Strategic Ventures's Debt to Equity Ratio for the fiscal year that ended in Mar. 2020 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(13.83	+	7.624)	/	-5.752
	=	-3.73

Cannabis Strategic Ventures's Debt to Equity Ratio for the quarter that ended in Jun. 2020 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(15.089	+	7.111)	/	-6.781
	=	-3.27

Cannabis Strategic Ventures (OTCPK:NUGS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Cannabis Strategic Ventures Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Cannabis Strategic Ventures's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Strategic Ventures (Cannabis Strategic Ventures) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Strategic Ventures (OTCPK:NUGS) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

9350 Wilshire Boulevard, Suite 203, Beverly Hills, CA, USA, 90212

Website

https://www.cannabisstrategic.com

Cannabis Strategic Ventures focuses on the medical and legal recreational cannabis sector. It provides temporary, permanent, and long-term staffing solutions, employment and human resources consulting to the legal Cannabis sector.

Executives

Gordon Samson	director, officer: Chief Financial Officer	9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Dane Brown	director, officer: VP, Corporate Development	9595 WILSHIRE BOULEVARD, SUITE 900 BEVERLY HILLS CA 90212
Christopher G Foster	director, officer: CFO, Secretary & Treasurer	5151 E. BROADWAY, SUITE 1600, TUCSON AZ 85711
Robert Hoegler	director, 10 percent owner, officer: President	#604 7040 GRANVILLE AVENUE RICHMOND A1 V6Y 3W5
Floyd Flaman	director, 10 percent owner, officer: SECRETARY/TREASURER	5621 52ND STREET DELTA A1 V4K 2C7
Scott Marshall	director, 10 percent owner, officer: President	2435 WEST 7TH AVENUE VANCOUVER A1 00000